Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +0.61% | +2.40% | +33.26% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.26% | 236.86Cr | |
+11.94% | 3,12900Cr | |
+10.56% | 8.68TCr | |
+6.08% | 7.86TCr | |
-14.77% | 5.39TCr | |
+26.21% | 4.82TCr | |
-23.40% | 4.74TCr | |
+29.50% | 4.56TCr | |
+76.40% | 4.1TCr | |
-9.24% | 2.49TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Transcript : Cellebrite DI Ltd., Q3 2023 Earnings Call, Nov 14, 2023